Role of type II NKT cells in the suppression of graft-versus-host disease.
Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
Engagement of FcyRIII provides activating signals to NKT cells that promote antibody-induced joint inflammation.
Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.
Distinct Expression Pattern of E-cadherin and β-catenin in Signet-Ring Cell Carcinoma Component of the Primary Pulmonary Adenocarcinoma.
